Sorrento Therapeutics Cleared For New $20M Loan In Ch. 11
Bankrupt drug developer Sorrento Therapeutics Inc. received court approval Wednesday for a $20 million debtor-in-possession financing package that will provide additional liquidity for the company as it pursues a sale and...To view the full article, register now.
Already a subscriber? Click here to view full article